Literature DB >> 2499274

Recent developments in the diagnosis and management of neurofibromatosis.

S M Huson1.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2499274      PMCID： PMC1792032          DOI： 10.1136/adc.64.5.745

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  17 in total

1.  Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma.

Authors:  B R Seizinger; R L Martuza; J F Gusella
Journal:  Nature       Date:  1986 Aug 14-20       Impact factor: 49.962

2.  Ophthalmic manifestations of neurofibromatosis.

Authors:  S Huson; D Jones; L Beck
Journal:  Br J Ophthalmol       Date:  1987-03       Impact factor: 4.638

3.  Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene.

Authors:  B R Seizinger; G A Rouleau; L J Ozelius; A H Lane; A G Faryniarz; M V Chao; S Huson; B R Korf; D M Parry; M A Pericak-Vance
Journal:  Cell       Date:  1987-06-05       Impact factor: 41.582

Review 4.  Neurofibromatosis: clinical heterogeneity.

Authors:  V M Riccardi
Journal:  Curr Probl Cancer       Date:  1982-08       Impact factor: 3.187

5.  Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen.

Authors:  V M Riccardi
Journal:  Arch Dermatol       Date:  1987-08

6.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.

Authors:  D Barker; E Wright; K Nguyen; L Cannon; P Fain; D Goldgar; D T Bishop; J Carey; B Baty; J Kivlin
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

7.  Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22.

Authors:  G A Rouleau; W Wertelecki; J L Haines; W J Hobbs; J A Trofatter; B R Seizinger; R L Martuza; D W Superneau; P M Conneally; J F Gusella
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

8.  Malignancy in neurofibromatosis.

Authors:  D G Hope; J J Mulvihill
Journal:  Adv Neurol       Date:  1981

9.  Neurofibromatosis in children with soft tissue sarcoma.

Authors:  A L Hartley; J M Birch; H B Marsden; M Harris; V Blair
Journal:  Pediatr Hematol Oncol       Date:  1988       Impact factor: 1.969

10.  Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata.

Authors:  R A Lewis; V M Riccardi
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079
View more
  13 in total

Review 1.  Types of psychiatric treatment: overview.

Authors:  P J Graham
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

2.  Risky Decision Making in Neurofibromatosis Type 1: An Exploratory Study.

Authors:  Rachel K Jonas; EunJi Roh; Caroline A Montojo; Laura A Pacheco; Tena Rosser; Alcino J Silva; Carrie E Bearden
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-03

3.  A clinical study of type 1 neurofibromatosis in north west England.

Authors:  J M McGaughran; D I Harris; D Donnai; D Teare; R MacLeod; R Westerbeek; H Kingston; M Super; R Harris; D G Evans
Journal:  J Med Genet       Date:  1999-03       Impact factor: 6.318

4.  Parents' experiences of caring for a young person with neurofibromatosis type 1 (NF1): a qualitative study.

Authors:  Jenny Barke; Jane Coad; Diana Harcourt
Journal:  J Community Genet       Date:  2015-07-23

5.  MRI findings in children with neurofibromatosis type 1: a prospective study.

Authors:  S Van Es; K N North; K McHugh; M De Silva
Journal:  Pediatr Radiol       Date:  1996-07

Review 6.  Recent developments in the application of the nonverbal learning disabilities model.

Authors:  Brenna C McDonald
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

7.  High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene.

Authors:  H Kehrer-Sawatzki; L Kluwe; C Sandig; M Kohn; K Wimmer; U Krammer; A Peyrl; D E Jenne; I Hansmann; V-F Mautner
Journal:  Am J Hum Genet       Date:  2004-07-15       Impact factor: 11.025

Review 8.  Neurofibromatosis type 1: new insights into neurocognitive issues.

Authors:  Maria T Acosta; Gerard A Gioia; Alcino J Silva
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

9.  Alterations in white matter microstructure in neurofibromatosis-1.

Authors:  Katherine H Karlsgodt; Tena Rosser; Evan S Lutkenhoff; Tyrone D Cannon; Alcino Silva; Carrie E Bearden
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

10.  Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients.

Authors:  Silke Frahm; Andreas Kurtz; Lan Kluwe; Faris Farassati; Reinhard E Friedrich; Victor F Mautner
Journal:  Cancer Cell Int       Date:  2004-05-17       Impact factor: 5.722
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.